CTI BioPharma Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2014	FY 2013	FY 2012	FY 2011
Period Ending	Jul '25 Jul 23, 2025	Dec '14 Dec 31, 2014	Dec '13 Dec 31, 2013	Dec '12 Dec 31, 2012	Dec '11 Dec 31, 2011
Market Capitalization	1	10	16	4	-
Market Cap Growth	-65.40%	-37.10%	259.89%	-	-
Enterprise Value	-	12	16	5	-
Last Close Price	0.01	0.46	0.72	0.30	1.75
PS Ratio	1.53	20.88	240.67	146.72	-
PB Ratio	-0.37	-17.61	41.98	-16.13	-
P/TBV Ratio	-	-	41.98	-	-
EV/Sales Ratio	-	25.21	246.40	175.37	-
Debt / Equity Ratio	-1.90	-5.27	1.83	-3.33	-2.53
Asset Turnover	0.14	0.19	0.05	0.03	-
Quick Ratio	0.03	0.72	0.18	0.07	0.50
Current Ratio	0.03	0.72	0.18	0.07	0.50
Return on Equity (ROE)	-	-	-2559.92%	-	-
Return on Assets (ROA)	-44.99%	-53.09%	-55.41%	-59.99%	-
Return on Capital (ROIC)	-59.95%	-75.01%	-92.48%	-84.08%	-
Earnings Yield	-405.93%	-23.01%	-8.44%	-40.49%	-
FCF Yield	-257.80%	-21.81%	-11.09%	-21.13%	-
Buyback Yield / Dilution	-5.32%	-14.46%	-30.21%	-145.01%	-

Updated Sep 2, 2015. Source: S&P Global Market Intelligence. Standard template. Financial Sources.